21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Interferon in Influenza
#16202Ungual/periungual compositions comprising morpholine compounds and water-soluble film-forming agents
#16203Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system
#16204Method and use of cold-pressed botanic seed oils for lowering blood pressure and LDL cholesterol
#16205Human monoclonal antibodies against CD20
#16206Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
#16207Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
#16208Drug releasing coatings for medical devices
#16209Compounds and compositions for delivering active agents
#16210CaM Kinase II Inhibitor Improves Retinoic Acid Therapy and Inhibits the Proliferation of Myeloid Leukemia Cells
#16211Botanical extract composition
#16212Hydroxamates as therapeutic agents
#16213Hydroxamates as therapeutic agents
#16214Combination of a NSAID and a PDE-4 inhibitor
#16215Anti-tumor activity of CCI-779 in papillary renal cell cancer
#16216Combination of Nilotinib with Farnesyl Transferase Inhibitors
#16217METHODS FOR ADMINISTERING DPD INHIBITORS IN COMBINATION WITH 5-FU AND 5-FU PRODRUGS
#16218Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
#16219Combination Drug for Treating Autoimmune Disease
#16220Compositions and Methods for Treatment of Psychiatric Disorders
#16221COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED DISORDERS
#16222Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators
#16223Combination of Organic Compounds
#16224Hydroquinone Ansamycin Formulations
#16225Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression
#16226Composition for inhibition of cathepsin K
#16227Use of phthalide derivatives
#16228Sterile suspensions of slightly soluble basic peptide complexes and pharmaceutical formulations containing them
#16229METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS
#16230Method of treating atherosclerosis
#16231PHARMACEUTICAL COMPOSITIONS
#16232Endoparasiticidal Compositions
#16233SPARC AND METHODS OF USE THEREOF
#16234Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds
#16235Treatment of Neurological Deficits in the Striatum or Substanta Nigra Pars Compacta
#16236Pharmaceutical composition comprising plant material or sp. alone or in association with other plant extracts for the reversion/combat and/or prevention of ventricular fibrillation
#16237Follicle-stimulating hormone reduction agent
#16238Methods for Reducing the Effects of Stress on Skin Condition
#16239Herbal mixture extract of rehmanniae radix preparata and acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis
#16240METHOD OF PROVIDING HEMOSTASIS IN ANTI-COAGULATED BLOOD
#16241Anti-tumor drug, medicament, composition, and use thereof
#16242Beverage health formulations
#16243COMPOSITION FOR IMPROVING IMMUNE SYSTEM HEALTH
#16244COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION
#16245Combination Methods and Therapies for Treating Opthalmic Conditions with 13-Cis-Retinyl Derivatives
#16246Antiprotozoal Agent
#16247Inhalation particles incorporating a combination of two or more active ingredients
#16248Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
#16249Mycobacteria expressing HIV-1 and malaria antigens
#16250Protocol for treatment of diabetes
#16251Composition for Treatment of Colds and Associated Symptoms
#16252Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
#16253COMBINATION ANTICOAGULANT THERAPY WITH A COMPOUND THAT ACTS AS A FACTOR XA INHIBITOR
#16254Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis
#16255Antagonist anti-CD40 antibodies
#16256Therapeutic agents and therapeutic methods for treating injured tissue
#16257Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids
#16258Nutritional formulation for promoting catch-up growth
#16259Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract
#16260Method of treating gastrointestinal diseases associated with species of genus
#16261Stem Cell Therapy for the Treatment of Autism and Other Disorders
#16262Use of Sdf-1 for the Treatment and/or Prevention of Neurological Diseases
#16263Methods and compositions for contributing to the treatment of cancers
#16264Anti-T Cell and Autoantigen Treatment of Autoimmune Disease
#16265Compositions for Lowering Serum Cholesterol and/or Triglycerides
#16266Bio-Co-Cr-Mo Alloy With Ion Elution Suppressed by Structure Control, And Process For Producing Same
#16267Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine
#16268MAGNESIUM COMPOSITIONS AND USES THEREOF FOR INCREASING LIFESPAN
#16269Magnesium compositions and uses thereof for neurological disorders
#16270Magnesium compositions and uses thereof for metabolic disorders
#16271Antimicrobial and Antinflammatory Composition
#16272Combinations of statins and anti-obesity agent and glitazones
#16273Imidazole and Thioazole Derivatives as Antiviral Agents
#16274NEW FORMULATIONS AND USE THEREOF
#16275Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
#16276Non Peptide Agonists and Antagonists of Adrenomedullin and Gastric Releasing Peptide
#16277Methods for the treatment of sleep disorders
#16278Use of memantine (namenda) to treat autism, compulsivity and impulsivity
#16279Method of Extending the Dose Range of Vitamin D Compounds
#16280ANTIVIRAL COMPOUNDS AND COMPOSITIONS
#16281Ophthalmic Pharmaceutical Compositions Based on Amino Acids and Sodium Hyaluronate
#16282Composition for promoting the maintenance and function of muscle-specific progenitor cells
#16283Antagonist Against Tolerance to Anticancer Drugs
#16284Use of GLP-2 in a combination treatment for bone-related disorders
#16285AGENTS THAT ALLEVIATE SIDE-EFFECTS CAUSED BY CHEMOTHERAPY AGENTS
#16286AMYLIN FORMULATIONS
#16287Method of production of artificial skin
#16288Methods for detection of lysosomal storage disease
#16289Methods for detection of lysosomal storage disease
#16290Magnesium-containing food compositions
#16291ACUTE AND CHRONIC HEARTBURN COMPOSITION AND METHOD
#16292COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION
#16293COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION
#16294Protein Kinase Modulation by Hops and Acacia Products
#16295Composition and Method For the Promotion of Hair Growth on a mammal
#16296Compounds and methods for promoting cellular health and treatment of cancer
#16297Standardized bee venom preparation
#16298COMPOSITION FOR STIMULATING DE NOVO BONE INDUCTION
#16299Combinations of statins and anti-obesity agent
#16300Pharmaceutical Compositions Useful in the Treatment of Pain
#16301Compositions and methods for inhibiting gastric acid secretion
#16302Melatonin-based composition for improved sleep
#16303COMPOSITION AND METHOD FOR REDUCING INFLAMMATION
#16304Melatonin-based composition for improved sleep
#16305Magnesium compositions and uses thereof
#16306METHOD OF TISSUE VASCULARIZATION
#16307Method for treatment of tendinosis with platelet rich plasma
#16308HDL-boosting combination therapy complexes
#16309Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
#16310TREATMENT WITH ANTI-VEGF ANTIBODIES
#16311Platform Antibody Compositions
#16312TREATMENT WITH ANTI-VEGF ANTIBODIES
#16313Pharmaceutical compositions
#16314VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
#16315Method of Treating Angiogenic Diseases
#16316Method of enhancing intestinal pinocytosis of immunoglobulins in postnatal domestic mammals
#16317Use of Hyaluronidase in Combination with Plasmin for the Induction of Posterior Vitreous Detachment
#16318Methods and devices for the sustained release of multiple drugs
#16319METHODS AND KITS FOR CO-ADMINISTRATION OF NUTRITIONAL SUPPLEMENTS
#16320Animal Medicament and Method of Manufacture
#16321Erythrocyte Function Modifying Substance
#16322Methods and systems for treating cell proliferation disorders
#16323Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
#16324Block Copolymer Compositions and Uses Thereof
#16325Rooibos Extract with Increased Aspalathin Content, Process for the Preparation of Such a Rooibos Extract , and Cosmetic Agent Containing Such a Rooibos Extract
#16326Pharmaceutical Compositions Comprising Higher Primary Aliphatic Alcohols and Hmg Coa Reductase Inhibitor and Process of Preparation Thereof
#16327DIETARY COMPOSITIONS CONTAINING ALPHA AMINO N-BUTYRATE AND METHODS OF ENHANCING LEAN BODY MASS
#16328Trans-Clomiphene for the Treatment of Benign Prostate Hypertrophy, Porstate Cancer, Hypogonadism Elevated Triglycerides and High Cholesterol
#16329Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
#16330METHODS OF ADMINISTRATION OF ADENOSINE A1 RECEPTOR ANTAGONISTS
#16331Preventive or Therapeutic Agent for Sleep Disorder
#16332Use of flibanserin in the treatment of obesity
#16333COMPOSITIONS AND METHODS FOR REDUCING CARDIOVASCULAR MORBIDITY AND/OR MORTALITY
#16334Soft anticholinergic zwitterions
#16335Oral contraceptive regimen
#16336New Combination 665
#16337COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER
#16338Split dose corticosteroid therapy
#16339Methods for reducing tackiness associated with a xanthine compound
#16340Induction of differential stress resistance and uses thereof
#16341Composition for the therapy of diabetes mellitus and adiposity
#16342Conjugate of insulin and vitamin B12 for oral delivery
#16343Method for controlling body weight in estrogen-insufficient women
#16344Compositions and methods for ameliorating hyperlipidemia
#16345COMPOSITION AND METHOD FOR WEIGHT LOSS
#16346Method and composition of a carminative herb or natural supplement to decrease the adverse events of orlistat, an oral lipase inhibitor
#16347Chinese medicinal compositions useful as anti-fatigue, anti-aging and gonadotrophic agent and processes for preparation thereof
#16348Compositions and methods for inhibiting 5-α reductase
#16349SEROTONIN AND CATECHOLAMINE SYSTEM SEGMENT OPTIMIZATION TECHNOLOGY
#16350Herbal formulation for the treatment of bone fractures and osseous defects
#16351Indibulin therapy
#16352Composition for Prevention and Treatment of Stretch Mark Comprising Citric Acid, Zinc and Arginine
#16353Pharmaceutical Combinations Containing Lamivudine, Stavudine and Nevirapine
#16354Biodegradable Nanoparticles Incorporating Highly Hydrophilic Positively Charged Drugs
#16355TARGETED ACTIVE AGENT DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES
#16356Methods and compositions for intraocular administration to treat ocular conditions
#16357Cell-based therapies for treating liver disease
#16358TARGETED DELIVERY AND EXPRESSION OF PROCOAGULANT HEMOSTATIC ACTIVITY
#16359TRANSDERMAL DELIVERY OF DEXAMETHASONE AND PROMETHAZINE
#16360Biodegradable, polymer coverings for breast implants
#16361COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUE AND CELLS FROM IMMUNE SYSTEM-MEDIATED DAMAGE
#16362TREATMENT WITH ANTI-VEGF ANTIBODIES
#16363Apo-2 ligand-anti-Her-2 antibody synergism
#16364ADJUVANT COMBINATIONS COMPRISING A MICROBIAL TLR AGONIST, A CD40 OR 4-1BB AGONIST, AND OPTIONALLY AN ANTIGEN AND THE USE THEREOF FOR INDUCING A SYNERGISTIC ENHANCEMENT IN CELLULAR IMMUNITY
#16365Methods for reducing viral load in HIV-1-infected patients
#16366INHIBITORS OF THE CERAMIDE METABOLIC PATHWAY AS ADJUNCTS TO OPIATES FOR PAIN
#16367Micronutrient formulations for pulmonary and heart health
#16368Methods and compositions for targeting proteins across the blood brain barrier
#16369Bone morphogenic protein binding peptide
#16370Method and reagents for the enhancement of virus transduction in the bladder epithelium
#16371PHARMACEUTICAL COMPOSITION COMPRISING A CYTOKINE
#16372Copolymers for suppression of autoimmune diseases, and methods of use
#16373Methods of treating neurological conditions with hematopoeitic growth factors
#16374Compositions and methods for inhibiting melanogenesis
#16375Composition for treating xerostomia or dry mouth
#16376Method and composition for increasing Erythropoietin
#16377Methods of modulating metastasis and skeletal related events resulting from metastases
#16378Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#1637927877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
#16380Compositions and method for treatment of chronic inflammatory diseases
#16381Composition and method for treating diabetes and metabolic disorders
#16382Treatment for Asthma and Arthritis and Other Inflammatory Diseases
#16383Methods And Compositions For Controlling Body Weight And Appetite
#16384Formulations of Ramipril
#16385METHOD FOR REDUCING OR ALLEVIATING INFLAMMATION IN THE DIGESTIVE TRACT
#16386Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
#16387Methods and apparatus for drug modeling and displaying drug models
#16388Antifolate agent combinations in the treatment of cancer
#16389Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists
#16390Hcv Inhibiting Sulfonamides
#16391Combination of Organic Compounds
#16392Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors
#16393Extended Use Combination Comprising Estrogens And Progestins
#16394Topical composition
#16395PHARMACEUTICAL PRODUCT CONTAINING PROGESTIN, GENISTEIN, AND VITAMIN D COMPOUND
#16396Compounds to promote regeneration of bone marrow
#16397Use Of Iron(III) Complex Compounds For The Preparation Of A Medicament For Oral Treatment Of Iron Deficiency States In Patients With Chronic Inflammatory Bowel Disease
#16398Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
#16399Further Medical Use Of A Botanical Drug Or Dietary Supplement
#16400Composition for diet comprising plant essential oil as active ingredient, sheet type composition for diet comprising thereof, percutaneous pharmaceutical agent for diet comprising thereof, and method for producing thereof
#16401Methods for treating oral cancers with herbal compositions
#16402Combined Preparation For Treating Sepsis
#16403Composition and method of use for the treatment of metabolic syndrome and inflammation
#16404USE OF ERIANIN IN PREPARING PHARMACEUTICAL FOR TREATING TUMORS
#16405COMPOSITIONS AND METHODS FOR ANTI-INFLAMMATORY TREATMENTS
#16406Nanoparticles for protein drug delivery
#16407Injectable sterile pharmaceutical composition with piperacillin sodium and tazobactam sodium as active principles
#16408Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
#16409ORGANIC COMPOUNDS
#16410HAEMOSTATIC COMPOSITION AND METHOD
#16411Pharmaceutical compositions
#16412Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
#16413Use of Erythropoietin for Enhancing Immune Responses and for Treatment of Lymphoproliferative Disorders
#16414Pharmaceutical compositions comprising old man's beard () and St. John's wort () and their use
#16415MULTIPLE SCLEROSIS THERAPY
#16416Treatment of Viral Infections
#16417Therapeutic treatments based on administration of small RNA fragments
#16418Compositions and methods for preventing or treating a viral infection
#16419Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#16420RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
#16421Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#16422Methods and compositions for treating lactose intolerance
#16423PREPARATIVE REGIMEN FOR ENGRAFTMENT, GROWTH AND DIFFERENTIATION OF NON-HEMATOPOEITIC CELLS IN VIVO AFTER TRANSPLANTATION
#16424Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
#16425Contrast Agents
#16426Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#16427Novel morphogenic protein compositions of matter
#16428USE OF NOREPINEPHRINE REUPTAKE MODULATORS FOR PREVENTING AND TREATING VASOMOTOR SYMPTOMS
#16429Orally Disintegrable Solid Preparation Comprising Povidone-Iodine
#16430METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS
#16431CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR COMBINATION
#16432FOOD EXTRACTS FOR TREATMENT OF LIPOPROTEIN ABNORMALITIES AND SKIN DISEASES AND SKIN DISORDERS
#16433DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF NEURALLY MEDIATED HYPOTENSION
#16434Formulation
#16435Agent For Suppressing Development of Tolerance to Narcotic Analgesics
#16436Method of treating immune pathologies with low dose estrogen
#16437Topical composition
#16438Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
#16439Use of bisphosphonates for the treatment of osteogenesis imperfecta
#16440COMPOSITION AND METHODS FOR TREATING OR PREVENTING DEGENERATIVE JOINT AND CARDIOVASCULAR CONDITIONS
#16441Compositions and kits for treating influenza
#16442Treatment and Control of Severe Infections Including Cystic Fibrosis
#16443Biphenyl inhibitors of carbonyl reductase
#16444Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors
#16445Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#16446PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#16447Prevention and treatment of amyloidogenic disease
#16448Compositions and methods for treating ophthalmic disorders
#16449Compounds having antitumor activity
#16450IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#16451SYSTEM FOR TREATING ADDICTIONS
#16452Use of a ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue
#16453KITS OF HYDRALAZINE COMPOUNDS AND ISOSORBIDE DINITRATE AND/OR ISOSORBIDE MONONITRATE
#16454PHARMACEUTICAL COMPOSITION CONTAINING NITRATE SOURCE AND AN ACIDIFYING AGENT FOR TREATING SKIN ISCHAEMIA
#16455Methods, Compositions and Articles of Manufacture for Treating Shock and Other Adverse Conditions
#16456Pharmaceutical composition for inhibiting the syndrome of snoring and preparation thereof
#16457Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
#16458Nutritional supplement for women
#16459Dietary supplement and related method
#16460Wound healing composition
#16461Combination of Rosiglitazone and Donepezil for Improvement of Cognitive Function
#16462THERAPEUTIC COMPOSITIONS AND METHODS
#16463Medicated gauze
#16464Methods of improving learning abilities of aged companion animals
#16465Bone cement compositions having fiber-reinforcement and/or increased flowability
#16466IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#16467Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect
#16468Eukaryotic Based Synergistic Formulation for Gastro-Intestinal Disorders
#16469Therapeutic compositions and methods useful in treating hepatitis
#16470Treatment of inflammatory diseases using placental stem cells
#16471Synergistic preservative systems and their use in topical compositions
#16472Kit for preparation of nano-targeted liposome drug in combined radionuclide therapy and chemotherapy
#16473Use of Arginine and Like Substances and methylglyoxal and Like Substances in Dialysis Machines
#16474Humanized antibodies that recognize beta amyloid peptide
#16475Tablets Comprising a High Load of Strontium
#16476Combination of Organic Compounds
#16477Combined agents for treatment of glaucoma
#16478Pharmaceutical composition having dopaminergic activity
#16479Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
#16480Quinuclidine derivatives and medicinal compositions containing the same
#16481Morphine and Morphine Precursors
#16482Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency
#16483Method of using SAHA and Erlotinib for treating cancer
#16484COMBINATION THERAPY
#16485Use of Hdac Inhibitors for the Treatment of Myeloma
#16486Combination of a Pd4 Inhibitor and a Tetrahydrobiopterin Derivative
#16487Compositions for providing vitamin D year round and uses thereof
#16488Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#16489Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis
#16490Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration
#16491Physiologically acceptable aqueous solutions and methods for their use
#16492Composition Containing Lotus Extract
#16493Compositions for producing satiety
#16494Solubilsation Products of an Active Ingredient Extract
#16495COMPOSITIONS OF EXTRACTS OF ALOE FOR ORAL ADMINISTRATION
#16496Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity
#16497Formulations containing and extracts which are useful in the treatment of obesity
#16498METHODS FOR PRODUCTION OF THE OXIDIZED GLUTATHIONE COMPOSITE WITH CIS-DIAMMINEDICHLOROPLATINUM AND PHARMACEUTICAL COMPOSITIONS BASED THEREOF REGULATING METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOTIC MECHANISMS FOR NORMAL AND TRANSFORMED CELLS
#16499REDUCTION OF REACTIVE OXYGEN SPECIES IN CHRONIC WOUND MANAGEMENT
#16500Anti tumor compositions and methods of use